Spanish medicine price discounts kick in
This article was originally published in Scrip
Obligatory 7.5% discounts on medicines in Spain, which came in to force on 1 June are already paying off for the government. This week it announced that the amount it paid per prescription had fallen by 6.2% in June 2010 compared with the previous June.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.